ProShares UltraShort FTSE Europe ETF (EPV)

On our risk desk, we are viewing EPV with extreme caution. The fund's 10-year maximum drawdown stands at a staggering -92.6% against the index's -24.9% decline over the same span. Even though Morningstar rates its riskVsCategory as Low, the portfolio risk score sits at 141, which puts it firmly in the extreme tier. Anyone treating this as a set-and-forget hedge is courting rapid capital destruction.

From a macro PM perspective, the prevailing trend in European equities makes holding EPV an uphill battle. The FTSE Developed Europe All Cap index posted a +17.35% return in 2025 and added another +9.29% YTD through early April 2026. This sustained structural uptrend is fundamentally hostile to a -2x daily-reset inverse product, creating a compounding decay loop that bleeds value even on flat consolidation days.

When analyzing execution feasibility for our clients, EPV fails the liquidity test completely. With an AUM hovering around $11.49M to $18M and average daily dollar volume near $414K, it is nowhere near the $200M liquidity floor required for a viable institutional hedging instrument. The transaction costs and slippage alone will eat up any short-term alpha you manage to capture during a sudden intraday dip.

Looking at the recent short interest data from June 2026, short positions in EPV dropped by 46.6% down to just 9,513 shares, leaving a days-to-cover ratio of a mere 0.6 days. With only 1.5% of shares sold short, speculative short-sellers have largely abandoned the ticker, reflecting a lack of conviction in an imminent European market downturn.

In our quantitative strategy sessions, we categorize EPV strictly as a short-duration tactical tool rather than a multi-month investment. The structural beta-slippage inherent in leveraged and inverse ETFs operating in trending-up markets destroys returns over time. Unless you are day-trading macro catalysts with strict intraday risk controls, holding this asset past a single session exposes you to severe path-dependent decay.